Mercer Global Advisors
FLGT icon

Mercer Global Advisors’s Fulgent Genetics FLGT Stock Holding History

Mercer Global Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
+7,560
New +$128K ﹤0.01% 3477

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Mercer Global Advisors's FLGT Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 7,560 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #3477 among its holdings.

125 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Mercer Global Advisors held 7,560 shares of Fulgent Genetics worth $155K as of Q2 2026.
  • Fulgent Genetics was a new Mercer Global Advisors position in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3477 holding.
  • 125 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.